CROMSOURCE GmbH
CROMSOURCE is an international full service CRO with comprehensive European and North American coverage and operates through three main divisions: Pharmaceutical, Medical Device and Staffing Solutions.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Exploring MINT: Part 3 – Nigeria
White Papers and Resources | August 22, 2014 | Inizio
In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.
3 Steps to Navigating Multichannel in Healthcare
White Papers and Resources | August 18, 2014 | Blue Latitude Health
You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign.
Exploring MINT: Part 2 – Indonesia
White Papers and Resources | August 12, 2014 | Inizio
In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...
Pegasus Wins ‘Consultancy of the Year’ at Communiqué Awards 2014
Press Releases | July 9, 2014 | Inizio
Pegasus, the UK’s leading independent health communications consultancy, picked up the much coveted ‘Consultancy of the Year’ award at last week’s Communiqué Awards 2014, fighting off stiff competition from the...
Free Thinking: Leveraging the ASEAN Market
White Papers and Resources | July 9, 2014 | Inizio
If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to...
Free Thinking: Biosimilars: Friend or foe to healthcare?
White Papers and Resources | July 9, 2014 | Inizio
Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.
The Next Billion Patients
White Papers and Resources | July 9, 2014 | Inizio
Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
Huge Untapped Growth Potential of ASEAN
White Papers and Resources | July 9, 2014 | Inizio
Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
The power of observation in gathering patient insights
White Papers and Resources | July 8, 2014 | Inizio
Mary Assimakopoulos, Founding Director of global pharma market research specialist Research Partnership discusses how pharma can benefit from improved patient understanding.
Market Insights Can Deliver a Better Patient Experience
White Papers and Resources | July 8, 2014 | Inizio
Mary Assimakopoulos, Founding Director of global pharma market research specialist Research Partnership discusses how pharma can benefit from improved patient understanding